Evidence map›Paper›PMID 35888130›Full record

ArticleLife (Basel, Switzerland)2022

Neonatal Antibiotic Treatment Can Affect Stool Pattern and Oral Tolerance in Preterm Infants.

Diana Verónica Reyes-García, Arturo Alejandro Canul-Euan, María Antonieta Rivera-Rueda, Claudia Edith Cruz-Alvarado, Luisa Bertha Bermejo-Martínez, Gabriela Arreola-Ramírez, Guadalupe Cordero-González, Sandra Carrera-Muiños, Juan Daniel Diaz-Valencia, Guadalupe Estrada-Gutiérrez and 2 more

Open access · goldAbstract read
In one paragraph

Article in Life (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Diana Verónica Reyes-GarcíaNeonatal Intensive Care Unit, National Institute of Perinatology "Isidro Espinosa de los Reyes", Mexico City 11000, Mexico.
Arturo Alejandro Canul-EuanDepartment of Developmental Neurobiology, National Institute of Perinatology "Isidro Espinosa de los Reyes", Mexico City 11000, Mexico.
María Antonieta Rivera-RuedaNeonatal Intensive Care Unit, National Institute of Perinatology "Isidro Espinosa de los Reyes", Mexico City 11000, Mexico.
Claudia Edith Cruz-AlvaradoNeonatal Intensive Care Unit, National Institute of Perinatology "Isidro Espinosa de los Reyes", Mexico City 11000, Mexico.
Luisa Bertha Bermejo-MartínezDepartment of Immunobiochemistry, National Institute of Perinatology "Isidro Espinosa de los Reyes", Mexico City 11000, Mexico.
Gabriela Arreola-RamírezDepartment of Pediatric Follow-Up, National Institute of Perinatology "Isidro Espinosa de los Reyes", Mexico City 11000, Mexico.
Guadalupe Cordero-GonzálezNeonatal Intensive Care Unit, National Institute of Perinatology "Isidro Espinosa de los Reyes", Mexico City 11000, Mexico.
Sandra Carrera-MuiñosNeonatal Intensive Care Unit, National Institute of Perinatology "Isidro Espinosa de los Reyes", Mexico City 11000, Mexico.
Juan Daniel Diaz-ValenciaDepartment of Physiology and Cellular Development, National Institute of Perinatology "Isidro Espinosa de los Reyes", Mexico City 11000, Mexico.
Guadalupe Estrada-GutiérrezResearch Direction, National Institute of Perinatology "Isidro Espinosa de los Reyes", Mexico City 11000, Mexico.ORCID 0000-0001-9551-9021
Claudine IrlesDepartment of Physiology and Cellular Development, National Institute of Perinatology "Isidro Espinosa de los Reyes", Mexico City 11000, Mexico.ORCID 0000-0003-3952-4007
Gabriela Gonzalez-PerezDepartment of Physiology and Cellular Development, National Institute of Perinatology "Isidro Espinosa de los Reyes", Mexico City 11000, Mexico.ORCID 0000-0002-3275-9172
Instituto Nacional de Perinatología · MX

Funding

Consejo Nacional de Ciencia y Tecnología FOSISS 289734Instituto Nacional de Perinatología 2017-2-61
6 · The paper itself

Abstract

Preterm neonates are at high risk of infectious and inflammatory diseases which require antibiotic treatment. Antibiotics influence neonatal gut microbiome development, and intestinal dysbiosis has been associated with delayed gastrointestinal transit. Neonates who take less time to pass meconium have a better tolerance to enteral feeding. We analyzed the effect of neonatal antibiotic treatment on the stool pattern and oral tolerance in 106 preterm infants < 33 weeks gestational age. Neonates were classified in 3 groups according to neonatal antibiotic (ABT) treatment days: no antibiotics, 3−7 d ABT, and ≥8 d ABT. Preterm infants from the ≥8 d ABT group took longer to pass meconium and to start green and yellow stools, took longer to reach 100 and 150 mL/kg/day, and reached reduced volumes in enteral feeds at day of life 14 and 28 than infants from no ABT and 3−7 d ABT groups. Multiple linear regression models showed that neonatal antibiotic treatment, birth weight, invasive mechanical ventilation, surfactant, enteral feeding start day, neonatal parenteral nutrition, and neonatal fasting days are associated with the stool pattern and oral tolerance in preterm infants.

Indexed as

delayed meconium passageempirical antibioticenteral feeding volumesgreen stoolsmeconiumneonatal antibioticpreterm infant feeding tolerancepreterm infant oral feedingpreterm infant stool patternyellow stools

Identifiers

PMID35888130
PMCPMC9319374
OpenAlexW4285496366

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.